Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Mesenteric ischemia after capecitabine treatment in rectal cancer and resultant short bowel syndrome is not an absolute contraindication for radical oncological treatment
Avtorji:ID Perpar, Ana (Avtor)
ID Brecelj, Erik (Avtor)
ID Rotovnik-Kozjek, Nada (Avtor)
ID Anderluh, Franc (Avtor)
ID Oblak, Irena (Avtor)
ID Skoblar Vidmar, Marija (Avtor)
ID Velenik, Vaneja (Avtor)
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (557,53 KB)
MD5: 1A15A6F4BB9855DE2BA23283D76C17A1
 
Jezik:Angleški jezik
Tipologija:1.03 - Drugi znanstveni članki
Organizacija:Logo OI - Onkološki inštitut Ljubljana
Povzetek:Thrombotic events, arterial or venous in origin, still remain a source of substantial morbidity and mortality in cancer patients. The propensity for their development in oncology patients is partially a consequence of the disease itself and partially a result of our attempts to treat it. One of the rarest and deadliest thromboembolic complications is arterial mesenteric ischemia. The high mortality rate is caused by its rarity and by its non-specific clinical presentation, both of which make early diagnosis and treatment difficult. Hence, most diagnoses and treatments occur late in the course of the disease. The issue survivors of arterial mesenteric ischemia may face is short bowel syndrome, which has become a chronic condition after the introduction of parenteral nutrition at home. We present a 73-year-old rectal cancer patient who developed acute arterial mesenteric thrombosis at the beginning of the pre-operative radiochemotherapy. Almost the entire length of his small intestine, except for the proximal 50 cm of it, and the ascending colon had to be resected. After multiorgan failure his condition improved, and he was able to successfully complete radical treatment (preoperative radiotherapy and surgery) for the rectal carcinoma, despite developing short bowel syndrome (SBS) and being dependent upon home-based parenteral nutrition to fully cover his nutritional needs. Mesenteric ischemia and resultant short bowel syndrome are not absolute contraindications for radical oncological treatment since such patients can still achieve long-term remission.
Ključne besede:acute mesenteric ischemia, capecitabine, multiorgan failure, rectal cancer, short bowel syndrome
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Datum objave:01.06.2015
Založnik:Association of Radiology and Oncology
Leto izida:2015
Št. strani:str. 181-184, VII
Številčenje:Vol. 49, no. 2
Izvor:Ljubljana
PID:20.500.12556/DiRROS-18808 Novo okno
UDK:616.351-006-005.4-08
ISSN pri članku:1318-2099
DOI:10.2478/raon-2014-0024 Novo okno
COBISS.SI-ID:281458176 Novo okno
Avtorske pravice:by Authors
Datum objave v DiRROS:23.04.2024
Število ogledov:691
Število prenosov:186
Metapodatki:XML DC-XML DC-RDF
:
PERPAR, Ana, BRECELJ, Erik, ROTOVNIK-KOZJEK, Nada, ANDERLUH, Franc, OBLAK, Irena, SKOBLAR VIDMAR, Marija in VELENIK, Vaneja, 2015, Mesenteric ischemia after capecitabine treatment in rectal cancer and resultant short bowel syndrome is not an absolute contraindication for radical oncological treatment. Radiology and oncology [na spletu]. 2015. Vol. 49, no. 2, p. 181–184, vii. [Dostopano 6 april 2025]. DOI 10.2478/raon-2014-0024. Pridobljeno s: https://dirros.openscience.si/IzpisGradiva.php?lang=slv&id=18808
Kopiraj citat
  
Objavi na:Bookmark and Share


Iščem podobna dela...Prosim, počakajte...
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Radiology and oncology
Skrajšan naslov:Radiol. oncol.
Založnik:Slovenian Medical Society - Section of Radiology, Croatian Medical Association - Croatian Society of Radiology
ISSN:1318-2099
COBISS.SI-ID:32649472 Novo okno

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:rak (medicina), danka, rak danke, zdravljenje, ishemija mezenterija, sindrom kratkega črevesa, zapleti


Nazaj